FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4295015266> ?p ?o ?g. }

• W4295015266 endingPage "991" @default.
• W4295015266 startingPage "991" @default.
• W4295015266 abstract "Importance Several less-invasive staging procedures have been proposed to replace axillary lymph node dissection (ALND) after neoadjuvant chemotherapy (NAC) in patients with initially clinically node-positive (cN+) breast cancer, but these procedures may fail to detect residual disease. Owing to the lack of high-level evidence, it is not yet clear which procedure is most optimal to replace ALND. Objective To determine the diagnostic accuracy of radioactive iodine seed placement in the axilla with sentinel lymph node biopsy (RISAS), a targeted axillary dissection procedure. Design, Setting, and Participants This was a prospective, multicenter, noninferiority, diagnostic accuracy trial conducted from March 1, 2017, to December 31, 2019. Patients were included within 14 institutions (general, teaching, and academic) throughout the Netherlands. Patients with breast cancer clinical tumor categories 1 through 4 (cT1-4; tumor diameter &amp;lt;2 cm and up to &amp;gt;5 cm or extension to the chest wall or skin) and pathologically proven positive axillary lymph nodes (ie, clinical node categories cN1, metastases to movable ipsilateral level I and/or level II axillary nodes; cN2, metastases to fixed or matted ipsilateral level I and/or level II axillary nodes; cN3b, metastases to ipsilateral level I and/or level II axillary nodes with metastases to internal mammary nodes) who were treated with NAC were eligible for inclusion. Data were analyzed from July 2020 to December 2021. Intervention Pre-NAC, the marking of a pathologically confirmed positive axillary lymph node with radioactive iodine seed (MARI) procedure, was performed and after NAC, sentinel lymph node biopsy (SLNB) combined with excision of the marked lymph node (ie, RISAS procedure) was performed, followed by ALND. Main Outcomes and Measures The identification rate, false-negative rate (FNR), and negative predictive value (NPV) were calculated for all 3 procedures: RISAS, SLNB, and MARI. The noninferiority margin of the observed FNR was 6.25% for the RISAS procedure. Results A total of 212 patients (median [range] age, 52 [22-77] years) who had cN+ breast cancer underwent the RISAS procedure and ALND. The identification rate of the RISAS procedure was 98.2% (223 of 227). The identification rates of SLNB and MARI were 86.4% (197 of 228) and 94.1% (224 of 238), respectively. FNR of the RISAS procedure was 3.5% (5 of 144; 90% CI, 1.38-7.16), and NPV was 92.8% (64 of 69; 90% CI, 85.37-97.10), compared with an FNR of 17.9% (22 of 123; 90% CI, 12.4%-24.5%) and NPV of 72.8% (59 of 81; 90% CI, 63.5%-80.8%) for SLNB and an FNR of 7.0% (10 of 143; 90% CI, 3.8%-11.6%) and NPV of 86.3% (63 of 73; 90% CI, 77.9%-92.4%) for the MARI procedure. In a subgroup of 174 patients in whom SLNB and the MARI procedure were successful and ALND was performed, FNR of the RISAS procedure was 2.5% (3 of 118; 90% CI, 0.7%-6.4%), compared with 18.6% (22 of 118; 90% CI, 13.0%-25.5%) for SLNB ( P &amp;lt; .001) and 6.8% (8 of 118; 90% CI, 3.4%-11.9%) for the MARI procedure ( P = .03). Conclusions and Relevance Results of this diagnostic study suggest that the RISAS procedure was the most feasible and accurate less-invasive procedure for axillary staging after NAC in patients with cN+ breast cancer." @default.
• W4295015266 created "2022-09-09" @default.
• W4295015266 creator A5000774074 @default.
• W4295015266 creator A5001433470 @default.
• W4295015266 creator A5004074611 @default.
• W4295015266 creator A5009594102 @default.
• W4295015266 creator A5019768495 @default.
• W4295015266 creator A5024375072 @default.
• W4295015266 creator A5024487588 @default.
• W4295015266 creator A5026288023 @default.
• W4295015266 creator A5030667936 @default.
• W4295015266 creator A5040642533 @default.
• W4295015266 creator A5040815074 @default.
• W4295015266 creator A5047164317 @default.
• W4295015266 creator A5048261461 @default.
• W4295015266 creator A5054109382 @default.
• W4295015266 creator A5061916989 @default.
• W4295015266 creator A5064077142 @default.
• W4295015266 creator A5064118249 @default.
• W4295015266 creator A5064243944 @default.
• W4295015266 creator A5064453966 @default.
• W4295015266 creator A5068217711 @default.
• W4295015266 creator A5082649984 @default.
• W4295015266 creator A5085458371 @default.
• W4295015266 date "2022-11-01" @default.
• W4295015266 modified "2023-10-06" @default.
• W4295015266 title "Diagnostic Accuracy of Radioactive Iodine Seed Placement in the Axilla With Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Node-Positive Breast Cancer" @default.
• W4295015266 cites W1966064734 @default.
• W4295015266 cites W2012620884 @default.
• W4295015266 cites W2103218083 @default.
• W4295015266 cites W2114220337 @default.
• W4295015266 cites W2172114428 @default.
• W4295015266 cites W2214028082 @default.
• W4295015266 cites W2226641828 @default.
• W4295015266 cites W2268087059 @default.
• W4295015266 cites W2571891920 @default.
• W4295015266 cites W2606483456 @default.
• W4295015266 cites W2618058692 @default.
• W4295015266 cites W2768918443 @default.
• W4295015266 cites W2773566007 @default.
• W4295015266 cites W2851557819 @default.
• W4295015266 cites W2895925444 @default.
• W4295015266 cites W2902218997 @default.
• W4295015266 cites W3012484416 @default.
• W4295015266 cites W3031231555 @default.
• W4295015266 cites W3096479038 @default.
• W4295015266 cites W3153619412 @default.
• W4295015266 cites W3183142448 @default.
• W4295015266 cites W4240915749 @default.
• W4295015266 doi "https://doi.org/10.1001/jamasurg.2022.3907" @default.
• W4295015266 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36069889" @default.
• W4295015266 hasPublicationYear "2022" @default.
• W4295015266 type Work @default.
• W4295015266 citedByCount "20" @default.
• W4295015266 countsByYear W42950152662023 @default.
• W4295015266 crossrefType "journal-article" @default.
• W4295015266 hasAuthorship W4295015266A5000774074 @default.
• W4295015266 hasAuthorship W4295015266A5001433470 @default.
• W4295015266 hasAuthorship W4295015266A5004074611 @default.
• W4295015266 hasAuthorship W4295015266A5009594102 @default.
• W4295015266 hasAuthorship W4295015266A5019768495 @default.
• W4295015266 hasAuthorship W4295015266A5024375072 @default.
• W4295015266 hasAuthorship W4295015266A5024487588 @default.
• W4295015266 hasAuthorship W4295015266A5026288023 @default.
• W4295015266 hasAuthorship W4295015266A5030667936 @default.
• W4295015266 hasAuthorship W4295015266A5040642533 @default.
• W4295015266 hasAuthorship W4295015266A5040815074 @default.
• W4295015266 hasAuthorship W4295015266A5047164317 @default.
• W4295015266 hasAuthorship W4295015266A5048261461 @default.
• W4295015266 hasAuthorship W4295015266A5054109382 @default.
• W4295015266 hasAuthorship W4295015266A5061916989 @default.
• W4295015266 hasAuthorship W4295015266A5064077142 @default.
• W4295015266 hasAuthorship W4295015266A5064118249 @default.
• W4295015266 hasAuthorship W4295015266A5064243944 @default.
• W4295015266 hasAuthorship W4295015266A5064453966 @default.
• W4295015266 hasAuthorship W4295015266A5068217711 @default.
• W4295015266 hasAuthorship W4295015266A5082649984 @default.
• W4295015266 hasAuthorship W4295015266A5085458371 @default.
• W4295015266 hasBestOaLocation W42950152662 @default.
• W4295015266 hasConcept C121608353 @default.
• W4295015266 hasConcept C126322002 @default.
• W4295015266 hasConcept C126838900 @default.
• W4295015266 hasConcept C179671157 @default.
• W4295015266 hasConcept C2775934546 @default.
• W4295015266 hasConcept C2776608951 @default.
• W4295015266 hasConcept C2777649267 @default.
• W4295015266 hasConcept C2778292576 @default.
• W4295015266 hasConcept C2780212769 @default.
• W4295015266 hasConcept C2780849966 @default.
• W4295015266 hasConcept C2908949552 @default.
• W4295015266 hasConcept C530470458 @default.
• W4295015266 hasConcept C71924100 @default.
• W4295015266 hasConceptScore W4295015266C121608353 @default.
• W4295015266 hasConceptScore W4295015266C126322002 @default.
• W4295015266 hasConceptScore W4295015266C126838900 @default.
• W4295015266 hasConceptScore W4295015266C179671157 @default.
• W4295015266 hasConceptScore W4295015266C2775934546 @default.
• W4295015266 hasConceptScore W4295015266C2776608951 @default.

• next